Cite
HARVARD Citation
Stringer, F. et al. (n.d.). Evaluation of the Impact of UGT Polymorphism on the Pharmacokinetics and Pharmacodynamics of the Novel PPAR Agonist Sipoglitazar. Journal of clinical pharmacology. pp. 256-263. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Stringer, F. et al. (n.d.). Evaluation of the Impact of UGT Polymorphism on the Pharmacokinetics and Pharmacodynamics of the Novel PPAR Agonist Sipoglitazar. Journal of clinical pharmacology. pp. 256-263. [Online].